# A Study of MSDx Complex 1 as a Marker for Therapy Response in Multiple Sclerosis

> **NCT01541618** · — · COMPLETED · sponsor: **MSDx, Inc.** · enrollment: 15 (actual)

## Conditions studied

- Relapsing Remitting Multiple Sclerosis

## Interventions

- **OTHER:** MSDX Complex-1 Biomarker test

## Key facts

- **NCT ID:** NCT01541618
- **Lead sponsor:** MSDx, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2020-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01541618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01541618, "A Study of MSDx Complex 1 as a Marker for Therapy Response in Multiple Sclerosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01541618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*